Physician profile
Rustin Ajdari
NPI 1447827951
$15,152.57
in general payments reported to CMS, 2019-2025
21 companies · $2,280 in 2025
The $2,280 reported for 2025 was more than what 91% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $3,917 · 2023: $1,012 · 2024: $7,944 · 2025: $2,280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,985 · Food and Beverage: $5,251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,985.40 |
| Food and Beverage | $5,250.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alon Medical Technology | $4,133.17 | 2022-2024 | |
| Stryker Corporation | $3,457.64 | 2022-2024 | Ortholoc 3di, Ortholoc 2 Lapifuse, Augment Injectable |
| Medline Industries LP | $1,447.44 | 2025 | |
| Orthofix Medical, INC. | $1,235.67 | 2024 | Truelok |
| Acumed LLC | $1,232.53 | 2024 | Acumed, Osteomed |
| Arthrex, INC. | $600.30 | 2024 | |
| Vilex LLC | $588.97 | 2025 | Redemption |
| Sanara Medtech INC. | $322.68 | 2024 | Celleraterx, Allocyte Plus |
| Zimmer Biomet Holdings, INC. | $301.14 | 2023-2025 | Tapestry, Activbraid |
| Smith+Nephew, INC. | $247.86 | 2023-2025 | Grafix Pl, Stravix Pl |
| Integra Lifesciences Corporation | $238.43 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Depuy Synthes Sales INC. | $235.78 | 2023-2025 | Motoband, Minibunion, Crosstie |
| Treace Medical Concepts, INC. | $207.73 | 2023-2025 | |
| Paragon 28, INC. | $173.41 | 2023 | Portfolio |
| Organogenesis INC. | $160.81 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $142.70 | 2023 | |
| Bone Support INC. | $142.56 | 2024 | Ceramentbone Void Filler, Cerament G |
| Averitas Pharma INC. | $124.99 | 2023 | Qutenza |
| Flower Orthopedics Coporation | $98.59 | 2023 | |
| Kerecis Limited | $42.18 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Boston Scientific Corporation | $17.99 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rustin Ajdari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.